[Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis].
Hejazi
R
R
Colombel
J-F
JF
Peyrin-Biroulet
L
L
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003711:Demyelinating Diseases / Q000139:chemically induced; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D009902:Optic Neuritis / Q000139:chemically induced*; D011350:Proctocolitis / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab